Company intelligence / Profile preview
Jiangsu Atom Bioscience & Pharmaceutical Co., Ltd.
Zhenjiang or Suzhou Industrial Park, Jiangsu, Chinaatomthera.us ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
The company’s lead drug ABP‑671, an orally administered URAT1 inhibitor for chronic gout and hyperuricemia, has shown good efficacy and safety in completed trials and entered global Phase III studies. ABP‑745 for acute gout has demonstrated preclinical efficacy/safety and entered early clinical development. Additional small molecule programs are at earlier stages. The company has raised over $165 million to date to support its clinical programs. Its lead program addresses significant unmet need due to limitations of current therapies for chronic gout.
- Therapeutic areas
- Metabolic DisordersOncologyRheumatologyImmunology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
China Medical System Holdings – exclusive commercialization agreement for Lingdolinurad (ABP–671) in China market
Beyond the preview
Go deeper on Jiangsu Atom Bioscience & Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangsu Atom Bioscience & Pharmaceutical Co., Ltd..